Literature DB >> 31801696

National trend of blood-stream infection attributable deaths caused by Staphylococcus aureus and Escherichia coli in Japan.

Shinya Tsuzuki1, Nobuaki Matsunaga2, Koji Yahara3, Yoshiaki Gu2, Kayoko Hayakawa2, Aki Hirabayashi3, Toshiki Kajihara3, Motoyuki Sugai3, Keigo Shibayama4, Norio Ohmagari5.   

Abstract

There has been scarce evidence about deaths due to blood stream infection (BSI) in Japan so far. The main objective of this study is to understand the epidemiological trend of deaths caused by BSIs due to Staphylococcus aureus and Escherichia coli including Methicillin-resistant S. aureus (MRSA) and fluoroquinolone-resistant E. coli (FQREC) at national level. We annually estimated the number of BSI caused by S. aureus and E. coli between 2011 and 2017 across Japan using comprehensive data of bacterial culturing and drug susceptibilities collected in Japan Nosocomial Infection Surveillance (JANIS). The number of death was estimated by using BSI mortality obtained from previous studies in Japan. The number of BSI death attributable to S. aureus was estimated to 17,412 in 2011 and 17,157 in 2017, respectively, out of the whole population (126.8 million) in Japan. Among them, cases attributed to MRSA accounted for 5924 (34.0%) in 2011, and decreased to 4224 (24.6%) cases in 2017. On the other hand, the number of BSI death attributable to E. coli was estimated to 9044 in 2011 and increased to 14,016 in 2017. Among them, cases attributed to FQREC accounted for 2045 (22.6%) in 2011 and increased to 3915 (27.9%) cases in 2017. The number of BSI death attributable to MRSA has been decreasing and that attributable to FQREC has been increasing. This study provides the first annual estimate of disease burden of BSI caused by antimicrobial resistant (AMR) bacteria in Japan, and basis for formulating health policy to deal with AMR.
Copyright © 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Blood-stream infection; Fluoroquinolone-resistant E. coli; MRSA; Mortality; Surveillance

Mesh:

Year:  2019        PMID: 31801696     DOI: 10.1016/j.jiac.2019.10.017

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  16 in total

Review 1.  Road to comprehensive estimation of antimicrobial resistance (AMR) disease burden in Japan.

Authors:  Shinya Tsuzuki; Nobuaki Matsunaga; Norio Ohmagari
Journal:  Glob Health Med       Date:  2020-06-30

2.  Relationship between mortality and molecular epidemiology of methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Masaru Shimizu; Toshihito Mihara; Junya Ohara; Keita Inoue; Mao Kinoshita; Teiji Sawa
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

3.  Raising awareness of antimicrobial resistance: comment on 'Reducing expectations for antibiotics in primary care: a randomised experiment to test the response to fear based messages about antimicrobial resistance'.

Authors:  Yoshiaki Gu
Journal:  BMC Med       Date:  2020-04-24       Impact factor: 8.775

4.  Prescription pattern analysis for antibiotics in working-age workers diagnosed with common cold.

Authors:  Yasuhiro Araki; Kenji Momo; Takeo Yasu; Kohtaro Ono; Takeshi Uchikura; Masayoshi Koinuma; Tadanori Sasaki
Journal:  Sci Rep       Date:  2021-11-22       Impact factor: 4.379

5.  Estimating the Economic and Clinical Value of Reducing Antimicrobial Resistance to Three Gram-negative Pathogens in Japan.

Authors:  Tetsuya Matsumoto; Oliver Darlington; Ryan Miller; Jason Gordon; Phil McEwan; Takahisa Ohashi; Amer Taie; Akira Yuasa
Journal:  J Health Econ Outcomes Res       Date:  2021-10-06

6.  Drug susceptibility and molecular epidemiology of Escherichia coli in bloodstream infections in Shanxi, China.

Authors:  Yanjun Zhang; Hairu Wang; Yanfang Li; Yabin Hou; Chonghua Hao
Journal:  PeerJ       Date:  2021-10-25       Impact factor: 2.984

7.  Institutional governance and responsiveness to antimicrobial resistance: a qualitative study of Australian hospital executives.

Authors:  Jennifer Broom; Alex Broom; Katherine Kenny; Jeffrey J Post; Pamela Konecny
Journal:  BMJ Open       Date:  2021-12-03       Impact factor: 2.692

8.  Immune Polarization Potential of the S. aureus Virulence Factors SplB and GlpQ and Modulation by Adjuvants.

Authors:  Daniel M Mrochen; Patricia Trübe; Ilka Jorde; Grazyna Domanska; Cindy van den Brandt; Barbara M Bröker
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

9.  Comparison of Antibiotic Resistance Profile of Escherichia coli between Pristine and Human-Impacted Sites in a River.

Authors:  Emi Nishimura; Masateru Nishiyama; Kei Nukazawa; Yoshihiro Suzuki
Journal:  Antibiotics (Basel)       Date:  2021-05-13

10.  Construction of Leaderless-Bacteriocin-Producing Bacteriophage Targeting E. coli and Neighboring Gram-Positive Pathogens.

Authors:  Yoshimitsu Masuda; Shun Kawabata; Tatsuya Uedoi; Ken-Ichi Honjoh; Takahisa Miyamoto
Journal:  Microbiol Spectr       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.